Home/Filings/4/0000950170-25-025771
4//SEC Filing

PYSZCZYMUKA GREG 4

Accession 0000950170-25-025771

CIK 0001403708other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 5:03 PM ET

Size

5.5 KB

Accession

0000950170-25-025771

Insider Transaction Report

Form 4
Period: 2025-02-20
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-20+5,8335,833 total
    Exercise: $5.26Exp: 2035-02-19Common Stock (5,833 underlying)
Footnotes (1)
  • [F1]1/3rd of the total number of shares of common stock subject to the option shall vest following each one-year period after February 20, 2025, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date, so that the option shall be fully vested on the third anniversary of the date of grant.

Documents

1 file

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1
  • filerCIK 0001952920

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:03 PM ET
Size
5.5 KB